BESPONSA
Active Ingredient: INOTUZUMAB OZOGAMICIN
Product Overview
About BESPONSA
BESPONSA is a prescription medication used to treat adult patients with relapsed or refractory acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) with 17p deletion or TP53 mutation.
Key Benefits & Uses
- Treatment of relapsed or refractory acute lymphoblastic leukemia (ALL)
- Treatment of relapsed or refractory chronic lymphocytic leukemia (CLL) with 17p deletion or TP53 mutation
Active Ingredient & Action
BESPONSA contains the active ingredient inotuzumab ozogamicin, a monoclonal antibody-drug conjugate that targets CD22, a protein found on the surface of B cells. Inotuzumab ozogamicin works by binding to CD22 and delivering a cytotoxic agent, calicheamicin, directly to the cancer cells, resulting in cell death.
Important Notes
It is essential to consult a healthcare professional before taking BESPONSA. The medication may cause serious side effects, including infusion reactions, neutropenia, thrombocytopenia, and hepatotoxicity. Patients should be closely monitored for signs of these adverse reactions and report any concerns to their healthcare provider promptly.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
